European Society for Medical Oncology (ESMO) 2023 – Abstracts #2362MO and #2359O
Dr. Arlene Siefker-Radtke, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center in Houston, TX discusses her presentation at ESMO 2023, abstracts #2362MO and #2359O on Erdafitinib (erda) from the Phase 3 THOR study. For more information visit: https://www.annalsofoncology.org/article/S0923-7534(23)04015-2/fulltext and https://www.nejm.org/doi/full/10.1056/NEJMoa2308849
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Arlene O Siefker-Radtke, MD is a Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX. She is a graduate of The Johns Hopkins University School of Medicine and has been in practice for more than 20 years.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
